Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Oct;41(10):2300–2301. doi: 10.1128/aac.41.10.2300

In vitro activities of the biguanide PS-15 and its metabolite, WR99210, against cycloguanil-resistant Plasmodium falciparum isolates from Thailand.

M D Edstein 1, S Bahr 1, B Kotecka 1, G D Shanks 1, K H Rieckmann 1
PMCID: PMC164114  PMID: 9333069

Abstract

The in vitro activities of the new biguanide PS-15 and its putative active metabolite, WR99210, were determined against seven different isolates or clones of Plasmodium falciparum. The mean 50% inhibitory concentrations of PS-15 and WR99210 were 1,015 and 0.06 ng/ml, respectively. WR99210 was up to 363 times more potent than cycloguanil, the active metabolite of proguanil, against cycloguanil-resistant parasites. The pronounced activity of WR99210 against multidrug-resistant P. falciparum indicates that further studies are required to determine the value of the prodrug, PS-15, as an antimalarial agent.

Full Text

The Full Text of this article is available as a PDF (119.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Canfield C. J., Milhous W. K., Ager A. L., Rossan R. N., Sweeney T. R., Lewis N. J., Jacobus D. P. PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists. Am J Trop Med Hyg. 1993 Jul;49(1):121–126. doi: 10.4269/ajtmh.1993.49.121. [DOI] [PubMed] [Google Scholar]
  2. Childs G. E., Lambros C. Analogues of N-benzyloxydihydrotriazines: in vitro antimalarial activity against Plasmodium falciparum. Ann Trop Med Parasitol. 1986 Apr;80(2):177–181. doi: 10.1080/00034983.1986.11812002. [DOI] [PubMed] [Google Scholar]
  3. Hughes W. T., Jacobus D. P., Canfield C., Killmar J. Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist. Antimicrob Agents Chemother. 1993 Jul;37(7):1417–1419. doi: 10.1128/aac.37.7.1417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Knight D. J., Mamalis P., Peters W. The antimalarial activity of N-benzyl-oxydihydrotriazines. III. The activity of 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(2,4,5,-trichloropropyloxy)-1,3,5-triazine hydrobromide (BRL 51084) and hydrochloride (BRL 6231). Ann Trop Med Parasitol. 1982 Feb;76(1):1–7. [PubMed] [Google Scholar]
  5. Knight D. J., Williamson P. The antimalarial activity of N-benzyl-oxydihydrotriazines. IV. The development of resistance to BRL 6231 (4,6-diamino-1,2-dihyydro-2-,2-dimethyl-1-(2,4,5-trichloropropyloxy)-1,3,5 triazine hydrochloride) by Plasmodium berghei. Ann Trop Med Parasitol. 1982 Feb;76(1):9–14. [PubMed] [Google Scholar]
  6. Lambros C., Vanderberg J. P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979 Jun;65(3):418–420. [PubMed] [Google Scholar]
  7. Limsomwong N., Pang L. W., Singharaj P. Malaria prophylaxis with proguanil in children living in a malaria-endemic area. Am J Trop Med Hyg. 1988 Mar;38(2):231–236. doi: 10.4269/ajtmh.1988.38.231. [DOI] [PubMed] [Google Scholar]
  8. Milhous W. K., Weatherly N. F., Bowdre J. H., Desjardins R. E. In vitro activities of and mechanisms of resistance to antifol antimalarial drugs. Antimicrob Agents Chemother. 1985 Apr;27(4):525–530. doi: 10.1128/aac.27.4.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Oduola A. M., Weatherly N. F., Bowdre J. H., Desjardins R. E. Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro. Exp Parasitol. 1988 Jun;66(1):86–95. doi: 10.1016/0014-4894(88)90053-7. [DOI] [PubMed] [Google Scholar]
  10. Rieckmann K. H., Yeo A. E., Edstein M. D. Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model. Trans R Soc Trop Med Hyg. 1996 Sep-Oct;90(5):568–571. doi: 10.1016/s0035-9203(96)90326-0. [DOI] [PubMed] [Google Scholar]
  11. Shanks G. D., Edstein M. D., Suriyamongkol V., Timsaad S., Webster H. K. Malaria chemoprophylaxis using proguanil/dapsone combinations on the Thai-Cambodian border. Am J Trop Med Hyg. 1992 Jun;46(6):643–648. doi: 10.4269/ajtmh.1992.46.643. [DOI] [PubMed] [Google Scholar]
  12. Thaithong S., Beale G. H. Resistance of ten Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests. Trans R Soc Trop Med Hyg. 1981;75(2):271–273. doi: 10.1016/0035-9203(81)90333-3. [DOI] [PubMed] [Google Scholar]
  13. Webster H. K., Boudreau E. F., Pavanand K., Yongvanitchit K., Pang L. W. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am J Trop Med Hyg. 1985 Mar;34(2):228–235. doi: 10.4269/ajtmh.1985.34.228. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES